Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.
Lancet
; 395(10234): 1407-1409, 2020 05 02.
Article
in English
| MEDLINE | ID: covidwho-47401
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Clinical Trials as Topic
/
Tumor Necrosis Factor-alpha
/
Coronavirus Infections
/
Inflammation
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Lancet
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS